*Illustration: watercolor with soft blurred strokes, paper texture. In the foreground — three stylized portfolios with charts rising in green lines. Background — muted gray-blue with a wet paper effect.* When directors of public companies buy shares with their own money, it's a signal worth deciphering. On April 30, three trades passed through the SEC database that are hard to call random. Behind each lies a specific logic. The first — a director of International Battery Metals made a large purchase. The company specializes in direct lithium extraction technologies. This is not a speculative bet but an investment in a production cycle that is already underway. When a director invests serious money, they see contracts the market hasn't noticed yet. The second — GE HealthCare. A rare case where both the CEO and corporate secretary buy shares on the same day. Synchronized actions by top management indicate one thing: the company's internal valuation is higher than the market's. GEHC spun off from General Electric in 2023 and is now building its own story in medical equipment and AI diagnostics. The third — Tsakos Energy Navigation, a Greek tanker operator. The CEO buys shares amid tensions in the Strait of Hormuz — freight rates are at multi-year highs. Buying shares with his own money in such a situation is not just faith in the company but a hedge against his own optimism. Three trades — three different sectors: lithium, medtech, tanker shipping. They share one thing: insiders buy when the market wavers. They see what is not visible in multiples. Track insider trades in seconds with ASI Biont — 1500 tokens to start.